Suppr超能文献

[通过酶标抗体技术展示肿瘤标志物对临床细胞学进行免疫化学研究]

[Immunochemical approach to clinical cytology by demonstration of tumor markers using enzyme-labeled antibody technic].

作者信息

Nishida K, Yamamoto T, Yoshioka K, Iida M, Miyagawa H, Yoshikawa T, Sugino S, Kondo M

出版信息

Gan No Rinsho. 1986 Jul;32(8):895-9.

PMID:2427754
Abstract

Demonstration of tumor markers using the enzyme-labeled antibody technique was evaluated as an immunochemical approach to cytodiagnosis. AFP, CEA, CA 19-9, or CA 125 were stained in specimens of pleural effusion, ascites, cerebrospinal fluid, hepatopancreatic tumor, bone marrow and spuata. Malignant cells of the cases with elevated marker levels in the body fluid were mostly positively stained. And, interestingly enough, some of the malignant cases showed positively, while diagnosis by Papanicolaou's staining was not established for malignancy. It is suggested that immunochemical cytology by tumor marker staining would be useful for analyzing malignant cells and helpful in clinical cytology.

摘要

采用酶标抗体技术检测肿瘤标志物被评估为一种用于细胞诊断的免疫化学方法。对胸腔积液、腹水、脑脊液、肝胰腺肿瘤、骨髓和痰液标本中的甲胎蛋白(AFP)、癌胚抗原(CEA)、糖类抗原19-9(CA 19-9)或糖类抗原125(CA 125)进行染色。体液中标志物水平升高的病例,其恶性细胞大多呈阳性染色。而且,有趣的是,一些恶性病例呈阳性反应,而巴氏染色未确诊为恶性肿瘤。提示通过肿瘤标志物染色进行免疫化学细胞学检查对分析恶性细胞有用,且有助于临床细胞学诊断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验